CA2691364C - High throughput nucleic acid sequencing by expansion - Google Patents
High throughput nucleic acid sequencing by expansion Download PDFInfo
- Publication number
- CA2691364C CA2691364C CA2691364A CA2691364A CA2691364C CA 2691364 C CA2691364 C CA 2691364C CA 2691364 A CA2691364 A CA 2691364A CA 2691364 A CA2691364 A CA 2691364A CA 2691364 C CA2691364 C CA 2691364C
- Authority
- CA
- Canada
- Prior art keywords
- tether
- subunit
- species
- template
- subunits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 157
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 155
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 155
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 61
- 239000000758 substrate Substances 0.000 claims abstract description 593
- 239000000523 sample Substances 0.000 claims abstract description 372
- 238000000034 method Methods 0.000 claims abstract description 360
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 207
- 239000002773 nucleotide Substances 0.000 claims abstract description 175
- 238000001447 template-directed synthesis Methods 0.000 claims abstract description 56
- 230000002068 genetic effect Effects 0.000 claims abstract description 42
- 125000005647 linker group Chemical group 0.000 claims description 247
- 230000015572 biosynthetic process Effects 0.000 claims description 170
- 238000003776 cleavage reaction Methods 0.000 claims description 143
- 230000007017 scission Effects 0.000 claims description 143
- 230000000295 complement effect Effects 0.000 claims description 112
- 239000000178 monomer Substances 0.000 claims description 76
- 238000003203 nucleic acid sequencing method Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 167
- 238000003786 synthesis reaction Methods 0.000 description 155
- 229920000642 polymer Polymers 0.000 description 107
- 108020004414 DNA Proteins 0.000 description 105
- 230000008569 process Effects 0.000 description 105
- 241000894007 species Species 0.000 description 105
- 102000053602 DNA Human genes 0.000 description 102
- 238000009396 hybridization Methods 0.000 description 102
- 239000000543 intermediate Substances 0.000 description 95
- -1 N4-ethanocytosine Chemical compound 0.000 description 89
- 238000001514 detection method Methods 0.000 description 78
- 150000001412 amines Chemical class 0.000 description 65
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 60
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 60
- 239000001226 triphosphate Substances 0.000 description 60
- 239000011324 bead Substances 0.000 description 53
- 238000006243 chemical reaction Methods 0.000 description 53
- 108091034117 Oligonucleotide Proteins 0.000 description 51
- 239000002243 precursor Substances 0.000 description 51
- 102000003960 Ligases Human genes 0.000 description 50
- 108090000364 Ligases Proteins 0.000 description 50
- 239000000412 dendrimer Substances 0.000 description 50
- 229920000736 dendritic polymer Polymers 0.000 description 48
- 238000006116 polymerization reaction Methods 0.000 description 48
- 101710163270 Nuclease Proteins 0.000 description 45
- 125000000524 functional group Chemical group 0.000 description 45
- 235000011178 triphosphate Nutrition 0.000 description 42
- 239000000499 gel Substances 0.000 description 41
- 238000013459 approach Methods 0.000 description 38
- 229920001223 polyethylene glycol Polymers 0.000 description 38
- 239000002202 Polyethylene glycol Substances 0.000 description 35
- GOUHYARYYWKXHS-UHFFFAOYSA-M 4-formylbenzoate Chemical compound [O-]C(=O)C1=CC=C(C=O)C=C1 GOUHYARYYWKXHS-UHFFFAOYSA-M 0.000 description 32
- 229910019142 PO4 Inorganic materials 0.000 description 32
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 32
- 238000005859 coupling reaction Methods 0.000 description 31
- 239000010452 phosphate Substances 0.000 description 31
- 239000012634 fragment Substances 0.000 description 30
- 239000000126 substance Substances 0.000 description 30
- 230000027455 binding Effects 0.000 description 29
- 238000002372 labelling Methods 0.000 description 29
- 108090000765 processed proteins & peptides Proteins 0.000 description 29
- 230000008878 coupling Effects 0.000 description 28
- 238000010168 coupling process Methods 0.000 description 28
- 239000002157 polynucleotide Substances 0.000 description 28
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 27
- 230000000903 blocking effect Effects 0.000 description 27
- 239000003153 chemical reaction reagent Substances 0.000 description 26
- 238000004132 cross linking Methods 0.000 description 26
- 239000000203 mixture Substances 0.000 description 26
- 230000004048 modification Effects 0.000 description 26
- 238000012986 modification Methods 0.000 description 26
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 23
- 230000001965 increasing effect Effects 0.000 description 23
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 23
- 239000007787 solid Substances 0.000 description 23
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 22
- 230000001419 dependent effect Effects 0.000 description 22
- 239000011159 matrix material Substances 0.000 description 22
- 102000040430 polynucleotide Human genes 0.000 description 22
- 108091033319 polynucleotide Proteins 0.000 description 22
- 239000002253 acid Substances 0.000 description 21
- 230000002255 enzymatic effect Effects 0.000 description 21
- 238000005755 formation reaction Methods 0.000 description 21
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 21
- 235000021317 phosphate Nutrition 0.000 description 21
- 238000011160 research Methods 0.000 description 21
- 239000011347 resin Substances 0.000 description 21
- 229920005989 resin Polymers 0.000 description 21
- 102000012410 DNA Ligases Human genes 0.000 description 20
- 108010061982 DNA Ligases Proteins 0.000 description 20
- 238000005516 engineering process Methods 0.000 description 20
- 125000006853 reporter group Chemical group 0.000 description 20
- 230000002441 reversible effect Effects 0.000 description 20
- 238000001327 Förster resonance energy transfer Methods 0.000 description 19
- 238000012412 chemical coupling Methods 0.000 description 19
- 238000010494 dissociation reaction Methods 0.000 description 19
- 230000005593 dissociations Effects 0.000 description 19
- 238000010348 incorporation Methods 0.000 description 19
- 230000005291 magnetic effect Effects 0.000 description 19
- 125000006850 spacer group Chemical group 0.000 description 19
- 230000008901 benefit Effects 0.000 description 18
- 102000004196 processed proteins & peptides Human genes 0.000 description 18
- 238000010511 deprotection reaction Methods 0.000 description 17
- 238000001962 electrophoresis Methods 0.000 description 17
- 150000002148 esters Chemical class 0.000 description 17
- 238000005259 measurement Methods 0.000 description 17
- 239000003607 modifier Substances 0.000 description 17
- 239000004971 Cross linker Substances 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 230000029087 digestion Effects 0.000 description 16
- 238000011049 filling Methods 0.000 description 16
- 238000007306 functionalization reaction Methods 0.000 description 16
- 150000004713 phosphodiesters Chemical group 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 16
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 16
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 15
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 14
- 239000000975 dye Substances 0.000 description 14
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 14
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 13
- 229920001577 copolymer Polymers 0.000 description 13
- 238000013461 design Methods 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000001712 DNA sequencing Methods 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 12
- 108010039918 Polylysine Proteins 0.000 description 12
- 230000000593 degrading effect Effects 0.000 description 12
- 239000002777 nucleoside Substances 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- 125000003396 thiol group Chemical group [H]S* 0.000 description 12
- 108010020346 Polyglutamic Acid Proteins 0.000 description 11
- 239000002671 adjuvant Substances 0.000 description 11
- 235000018417 cysteine Nutrition 0.000 description 11
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 11
- 235000011180 diphosphates Nutrition 0.000 description 11
- 150000004712 monophosphates Chemical class 0.000 description 11
- 229920000656 polylysine Polymers 0.000 description 11
- 238000000746 purification Methods 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 102100034343 Integrase Human genes 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 150000008300 phosphoramidites Chemical class 0.000 description 10
- 229920001184 polypeptide Polymers 0.000 description 10
- 229920002477 rna polymer Polymers 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 125000000824 D-ribofuranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@]([H])(O[H])[C@]1([H])O[H] 0.000 description 9
- 239000004472 Lysine Substances 0.000 description 9
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 9
- 108091028664 Ribonucleotide Proteins 0.000 description 9
- 230000001588 bifunctional effect Effects 0.000 description 9
- 239000000470 constituent Substances 0.000 description 9
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 9
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 9
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 9
- 239000003446 ligand Substances 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 239000002336 ribonucleotide Substances 0.000 description 9
- 125000002652 ribonucleotide group Chemical group 0.000 description 9
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 9
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 8
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
- 150000001408 amides Chemical class 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000000137 annealing Methods 0.000 description 8
- 239000000386 donor Substances 0.000 description 8
- 238000003505 heat denaturation Methods 0.000 description 8
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
- 108010083644 Ribonucleases Proteins 0.000 description 7
- 102000006382 Ribonucleases Human genes 0.000 description 7
- 238000002144 chemical decomposition reaction Methods 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 7
- 229930195712 glutamate Natural products 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 7
- 238000010647 peptide synthesis reaction Methods 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 108020004635 Complementary DNA Proteins 0.000 description 6
- 108010060248 DNA Ligase ATP Proteins 0.000 description 6
- 102000008158 DNA Ligase ATP Human genes 0.000 description 6
- 108010017826 DNA Polymerase I Proteins 0.000 description 6
- 102000004594 DNA Polymerase I Human genes 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 6
- 229940104302 cytosine Drugs 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 239000012160 loading buffer Substances 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 230000000269 nucleophilic effect Effects 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- 150000003573 thiols Chemical class 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 5
- QSECPQCFCWVBKM-UHFFFAOYSA-N 2-iodoethanol Chemical compound OCCI QSECPQCFCWVBKM-UHFFFAOYSA-N 0.000 description 5
- 108091023037 Aptamer Proteins 0.000 description 5
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 5
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 108091093037 Peptide nucleic acid Proteins 0.000 description 5
- 108010029485 Protein Isoforms Proteins 0.000 description 5
- 102000001708 Protein Isoforms Human genes 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 229920001400 block copolymer Polymers 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000001351 cycling effect Effects 0.000 description 5
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000005684 electric field Effects 0.000 description 5
- IYBKWXQWKPSYDT-UHFFFAOYSA-L ethylene glycol disuccinate bis(sulfo-N-succinimidyl) ester sodium salt Chemical compound [Na+].[Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCC(=O)OCCOC(=O)CCC(=O)ON1C(=O)C(S([O-])(=O)=O)CC1=O IYBKWXQWKPSYDT-UHFFFAOYSA-L 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 238000005304 joining Methods 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 5
- 230000005298 paramagnetic effect Effects 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- 229920000515 polycarbonate Polymers 0.000 description 5
- 239000004417 polycarbonate Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 238000005382 thermal cycling Methods 0.000 description 5
- 150000007970 thio esters Chemical class 0.000 description 5
- QQVDJLLNRSOCEL-UHFFFAOYSA-N (2-aminoethyl)phosphonic acid Chemical class [NH3+]CCP(O)([O-])=O QQVDJLLNRSOCEL-UHFFFAOYSA-N 0.000 description 4
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 4
- WQADWIOXOXRPLN-UHFFFAOYSA-N 1,3-dithiane Chemical compound C1CSCSC1 WQADWIOXOXRPLN-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N 4-methyl-1h-indole Chemical compound CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 4
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 4
- PEHVGBZKEYRQSX-UHFFFAOYSA-N 7-deaza-adenine Chemical compound NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 4
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 4
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 4
- 101710203526 Integrase Proteins 0.000 description 4
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
- 125000003636 chemical group Chemical group 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 229940099500 cystamine Drugs 0.000 description 4
- 239000005547 deoxyribonucleotide Substances 0.000 description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 4
- 239000000539 dimer Substances 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 238000003205 genotyping method Methods 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 4
- ZJTJUVIJVLLGSP-UHFFFAOYSA-N lumichrome Chemical compound N1C(=O)NC(=O)C2=C1N=C1C=C(C)C(C)=CC1=N2 ZJTJUVIJVLLGSP-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 125000003835 nucleoside group Chemical group 0.000 description 4
- 239000002751 oligonucleotide probe Substances 0.000 description 4
- 150000008298 phosphoramidates Chemical group 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229920000151 polyglycol Polymers 0.000 description 4
- 239000010695 polyglycol Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 230000037452 priming Effects 0.000 description 4
- 150000003212 purines Chemical group 0.000 description 4
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
- 229920005604 random copolymer Polymers 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 229960002317 succinimide Drugs 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- 229940104230 thymidine Drugs 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000005641 tunneling Effects 0.000 description 4
- 229940035893 uracil Drugs 0.000 description 4
- 238000012070 whole genome sequencing analysis Methods 0.000 description 4
- 229940075420 xanthine Drugs 0.000 description 4
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 3
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 3
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 3
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 3
- 108010001132 DNA Polymerase beta Proteins 0.000 description 3
- 102100022302 DNA polymerase beta Human genes 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 3
- 101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical group O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
- 229930010555 Inosine Natural products 0.000 description 3
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108060004795 Methyltransferase Proteins 0.000 description 3
- 101100545180 Mus musculus Zc3h12d gene Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920001744 Polyaldehyde Polymers 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 229920000037 Polyproline Polymers 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 108010066717 Q beta Replicase Proteins 0.000 description 3
- 108010065868 RNA polymerase SP6 Proteins 0.000 description 3
- 101710137500 T7 RNA polymerase Proteins 0.000 description 3
- 108010017842 Telomerase Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 229960005305 adenosine Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 3
- 229910052796 boron Inorganic materials 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000010382 chemical cross-linking Methods 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000010894 electron beam technology Methods 0.000 description 3
- 238000001493 electron microscopy Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 102000013165 exonuclease Human genes 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 230000037433 frameshift Effects 0.000 description 3
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 150000002463 imidates Chemical class 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229960003786 inosine Drugs 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 239000002090 nanochannel Substances 0.000 description 3
- 239000002159 nanocrystal Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 125000006502 nitrobenzyl group Chemical group 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 238000002515 oligonucleotide synthesis Methods 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920000768 polyamine Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 229920001228 polyisocyanate Polymers 0.000 description 3
- 239000005056 polyisocyanate Substances 0.000 description 3
- 229920000441 polyisocyanide Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000013545 self-assembled monolayer Substances 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- MIDXXTLMKGZDPV-UHFFFAOYSA-M sodium;1-[6-(2,5-dioxopyrrol-1-yl)hexanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCCCN1C(=O)C=CC1=O MIDXXTLMKGZDPV-UHFFFAOYSA-M 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 230000005945 translocation Effects 0.000 description 3
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 3
- TYKASZBHFXBROF-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-(2,5-dioxopyrrol-1-yl)acetate Chemical compound O=C1CCC(=O)N1OC(=O)CN1C(=O)C=CC1=O TYKASZBHFXBROF-UHFFFAOYSA-N 0.000 description 2
- VRDGQQTWSGDXCU-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-iodoacetate Chemical compound ICC(=O)ON1C(=O)CCC1=O VRDGQQTWSGDXCU-UHFFFAOYSA-N 0.000 description 2
- JKHVDAUOODACDU-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(2,5-dioxopyrrol-1-yl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCN1C(=O)C=CC1=O JKHVDAUOODACDU-UHFFFAOYSA-N 0.000 description 2
- JUDOLRSMWHVKGX-UHFFFAOYSA-N 1,1-dioxo-1$l^{6},2-benzodithiol-3-one Chemical compound C1=CC=C2C(=O)SS(=O)(=O)C2=C1 JUDOLRSMWHVKGX-UHFFFAOYSA-N 0.000 description 2
- WKKCYLSCLQVWFD-UHFFFAOYSA-N 1,2-dihydropyrimidin-4-amine Chemical compound N=C1NCNC=C1 WKKCYLSCLQVWFD-UHFFFAOYSA-N 0.000 description 2
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 2
- HASUWNAFLUMMFI-UHFFFAOYSA-N 1,7-dihydropyrrolo[2,3-d]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)NC2=C1C=CN2 HASUWNAFLUMMFI-UHFFFAOYSA-N 0.000 description 2
- OJQSISYVGFJJBY-UHFFFAOYSA-N 1-(4-isocyanatophenyl)pyrrole-2,5-dione Chemical compound C1=CC(N=C=O)=CC=C1N1C(=O)C=CC1=O OJQSISYVGFJJBY-UHFFFAOYSA-N 0.000 description 2
- LNRCBWCMVHSMBJ-GJMOJQLCSA-N 1-[(2r,4s,5r)-5-(hydroxymethyl)-4-sulfanyloxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](S)C1 LNRCBWCMVHSMBJ-GJMOJQLCSA-N 0.000 description 2
- FPKVOQKZMBDBKP-UHFFFAOYSA-N 1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 FPKVOQKZMBDBKP-UHFFFAOYSA-N 0.000 description 2
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 2
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 2
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 2
- NHZLLKNRTDIFAD-UHFFFAOYSA-N 2,5-dihydro-1,3-oxazole Chemical compound C1OCN=C1 NHZLLKNRTDIFAD-UHFFFAOYSA-N 0.000 description 2
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 2
- XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical compound NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 description 2
- GIIGHSIIKVOWKZ-UHFFFAOYSA-N 2h-triazolo[4,5-d]pyrimidine Chemical group N1=CN=CC2=NNN=C21 GIIGHSIIKVOWKZ-UHFFFAOYSA-N 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
- OGVOXGPIHFKUGM-UHFFFAOYSA-N 3H-imidazo[2,1-i]purine Chemical compound C12=NC=CN2C=NC2=C1NC=N2 OGVOXGPIHFKUGM-UHFFFAOYSA-N 0.000 description 2
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 2
- SRFDORQOCXQRFZ-UHFFFAOYSA-N 4-methylbenzenesulfonamide;phenylmethanimine Chemical compound N=CC1=CC=CC=C1.CC1=CC=C(S(N)(=O)=O)C=C1 SRFDORQOCXQRFZ-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 2
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
- LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- ZZOKVYOCRSMTSS-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl carbamate Chemical compound C1=CC=C2C(COC(=O)N)C3=CC=CC=C3C2=C1 ZZOKVYOCRSMTSS-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 102100030374 Actin, cytoplasmic 2 Human genes 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 108010063905 Ampligase Proteins 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 101900063352 Escherichia coli DNA ligase Proteins 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- 229920000028 Gradient copolymer Polymers 0.000 description 2
- 101000773237 Homo sapiens Actin, cytoplasmic 2 Proteins 0.000 description 2
- 101001099381 Homo sapiens Peroxisomal biogenesis factor 19 Proteins 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 2
- 108010043958 Peptoids Chemical class 0.000 description 2
- 102100038883 Peroxisomal biogenesis factor 19 Human genes 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 229920002396 Polyurea Polymers 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 101710086015 RNA ligase Proteins 0.000 description 2
- 108090001087 RNA ligase (ATP) Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 2
- 101000803944 Thermus filiformis DNA ligase Proteins 0.000 description 2
- 101000803951 Thermus scotoductus DNA ligase Proteins 0.000 description 2
- 101000803959 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) DNA ligase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000007801 affinity label Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 238000004630 atomic force microscopy Methods 0.000 description 2
- HUMNYLRZRPPJDN-KWCOIAHCSA-N benzaldehyde Chemical group O=[11CH]C1=CC=CC=C1 HUMNYLRZRPPJDN-KWCOIAHCSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000002210 biocatalytic effect Effects 0.000 description 2
- 238000010504 bond cleavage reaction Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 150000001945 cysteines Chemical class 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000000688 desorption electrospray ionisation Methods 0.000 description 2
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 2
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000006872 enzymatic polymerization reaction Methods 0.000 description 2
- 150000002168 ethanoic acid esters Chemical class 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229920005570 flexible polymer Polymers 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- 238000001215 fluorescent labelling Methods 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 150000002332 glycine derivatives Chemical class 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 125000001921 locked nucleotide group Chemical group 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical class OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001308 poly(aminoacid) Polymers 0.000 description 2
- 229920000889 poly(m-phenylene isophthalamide) Polymers 0.000 description 2
- 229920000548 poly(silane) polymer Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002857 polybutadiene Polymers 0.000 description 2
- 229920001896 polybutyrate Polymers 0.000 description 2
- 229920002643 polyglutamic acid Polymers 0.000 description 2
- 229920000232 polyglycine polymer Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 238000001955 polymer synthesis method Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920000193 polymethacrylate Polymers 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 108010026466 polyproline Proteins 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001290 polyvinyl ester Polymers 0.000 description 2
- 150000003141 primary amines Chemical group 0.000 description 2
- JIQXKYSNGXUDJU-UHFFFAOYSA-N propan-2-ylidenehydrazine Chemical compound CC(C)=NN JIQXKYSNGXUDJU-UHFFFAOYSA-N 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 229920013730 reactive polymer Polymers 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 238000007480 sanger sequencing Methods 0.000 description 2
- 238000004574 scanning tunneling microscopy Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- ULARYIUTHAWJMU-UHFFFAOYSA-M sodium;1-[4-(2,5-dioxopyrrol-1-yl)butanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCN1C(=O)C=CC1=O ULARYIUTHAWJMU-UHFFFAOYSA-M 0.000 description 2
- VUFNRPJNRFOTGK-UHFFFAOYSA-M sodium;1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 VUFNRPJNRFOTGK-UHFFFAOYSA-M 0.000 description 2
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000013179 statistical model Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 2
- XBXCNNQPRYLIDE-UHFFFAOYSA-N tert-butylcarbamic acid Chemical compound CC(C)(C)NC(O)=O XBXCNNQPRYLIDE-UHFFFAOYSA-N 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 2
- 229950000329 thiouracil Drugs 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000000101 transmission high energy electron diffraction Methods 0.000 description 2
- 239000013638 trimer Substances 0.000 description 2
- BZVJOYBTLHNRDW-UHFFFAOYSA-N triphenylmethanamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N)C1=CC=CC=C1 BZVJOYBTLHNRDW-UHFFFAOYSA-N 0.000 description 2
- FTYUGLBWKRXQBD-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCOCCOCCOCCOCCOCCC(=O)ON1C(=O)CCC1=O FTYUGLBWKRXQBD-UHFFFAOYSA-N 0.000 description 1
- PVGATNRYUYNBHO-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-(2,5-dioxopyrrol-1-yl)butanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCN1C(=O)C=CC1=O PVGATNRYUYNBHO-UHFFFAOYSA-N 0.000 description 1
- YNPMOLOLDXXLMW-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-hydrazinylpyridine-3-carboxylate Chemical compound NNC1=CC=NC=C1C(=O)ON1C(=O)CCC1=O YNPMOLOLDXXLMW-UHFFFAOYSA-N 0.000 description 1
- COPYCEBYTZPWDJ-XLPZGREQSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-3-sulfanylpyrimidine-2,4-dione Chemical compound O=C1N(S)C(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 COPYCEBYTZPWDJ-XLPZGREQSA-N 0.000 description 1
- DLVMMFJNFYADRO-WPRFRAJKSA-N 1-[(2r,4s,5s)-4-hydroxy-5-[hydroxy(sulfanyl)methyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](C(O)S)[C@@H](O)C1 DLVMMFJNFYADRO-WPRFRAJKSA-N 0.000 description 1
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-Tetramethylpiperidine Substances CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 description 1
- JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 description 1
- GOQVCESMVSFYEM-UHFFFAOYSA-N 2-[2-hydroxyethyl(phosphono)amino]acetic acid Chemical compound OCCN(P(O)(O)=O)CC(O)=O GOQVCESMVSFYEM-UHFFFAOYSA-N 0.000 description 1
- DZADYMNFGABIKJ-UHFFFAOYSA-N 2-[[2-aminoethoxy(hydroxy)phosphoryl]amino]acetic acid Chemical compound NCCOP(O)(=O)NCC(O)=O DZADYMNFGABIKJ-UHFFFAOYSA-N 0.000 description 1
- QWTBDIBOOIAZEF-UHFFFAOYSA-N 3-[chloro-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile Chemical compound CC(C)N(C(C)C)P(Cl)OCCC#N QWTBDIBOOIAZEF-UHFFFAOYSA-N 0.000 description 1
- LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 1
- DCXJOVUZENRYSH-UHFFFAOYSA-N 4,4-dimethyloxazolidine-N-oxyl Chemical compound CC1(C)COCN1[O] DCXJOVUZENRYSH-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- MOBQGYGNNQUMIN-UHFFFAOYSA-N 6-aminohexoxyphosphonamidic acid Chemical compound NCCCCCCOP(N)(O)=O MOBQGYGNNQUMIN-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- IUMNWHADVMZBJV-UHFFFAOYSA-N 6-nitrobenzo[de]isoquinoline-1,3-dione Chemical compound O=C1NC(=O)C2=CC=CC3=C2C1=CC=C3[N+](=O)[O-] IUMNWHADVMZBJV-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 239000012116 Alexa Fluor 680 Substances 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- SPNJNGBLQSTLMI-UHFFFAOYSA-N CC(C)=NN.NNC1=CC=NC=C1C(=O)ON1C(=O)CCC1=O Chemical compound CC(C)=NN.NNC1=CC=NC=C1C(=O)ON1C(=O)CCC1=O SPNJNGBLQSTLMI-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 230000000970 DNA cross-linking effect Effects 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000035699 Distal ileal obstruction syndrome Diseases 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 241000447437 Gerreidae Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 description 1
- 241000590478 Hypna Species 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 229910013462 LiC104 Inorganic materials 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- JRXUGRPTDIHPMS-UHFFFAOYSA-N NCCOP(O)=O Chemical compound NCCOP(O)=O JRXUGRPTDIHPMS-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- NVPVJOAIHREACE-UHFFFAOYSA-N OP(O)(O)=O.N1C=NC=C2N=CC=C21 Chemical compound OP(O)(O)=O.N1C=NC=C2N=CC=C21 NVPVJOAIHREACE-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- RPDUDBYMNGAHEM-UHFFFAOYSA-N PROXYL Chemical compound CC1(C)CCC(C)(C)N1[O] RPDUDBYMNGAHEM-UHFFFAOYSA-N 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 201000010273 Porphyria Cutanea Tarda Diseases 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108091028733 RNTP Proteins 0.000 description 1
- 108091036333 Rapid DNA Proteins 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 1
- OEUXFECIJDETRF-XVFCMESISA-N [(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-oxo-2-sulfanylidenepyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1N1C(=S)NC(=O)C=C1 OEUXFECIJDETRF-XVFCMESISA-N 0.000 description 1
- KQJMOJABMFAPCE-UUOKFMHZSA-N [(2r,3s,4r,5r)-5-(2,6-diaminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound C12=NC(N)=NC(N)=C2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O KQJMOJABMFAPCE-UUOKFMHZSA-N 0.000 description 1
- BPWVHBCPZTVLLY-XVFCMESISA-N [(2r,3s,4r,5r)-5-(4-amino-2-sulfanylidenepyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 BPWVHBCPZTVLLY-XVFCMESISA-N 0.000 description 1
- VDFDVPDZCKHWRP-YLKYYZSCSA-N [(2r,3s,5s)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-5-sulfanyloxolan-2-yl]methoxyphosphonamidous acid Chemical compound O=C1NC(=O)C(C)=CN1[C@]1(S)O[C@H](COP(N)O)[C@@H](O)C1 VDFDVPDZCKHWRP-YLKYYZSCSA-N 0.000 description 1
- IJZPDRFZDDISAG-USBNGQNGSA-N [(2r,3s,5s)-5-amino-5-[6-amino-8-(6-aminohexyl)purin-9-yl]-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical class NCCCCCCC1=NC2=C(N)N=CN=C2N1[C@@]1(N)C[C@H](O)[C@@H](COP(O)(O)=O)O1 IJZPDRFZDDISAG-USBNGQNGSA-N 0.000 description 1
- OTYCIBMYFBOSMG-XNIJJKJLSA-N [[(2r,3s,4r,5r)-5-[6-(6-aminohexylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=NC=2C(NCCCCCCN)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O OTYCIBMYFBOSMG-XNIJJKJLSA-N 0.000 description 1
- HSXRRQRNDFXLQW-YNEHKIRRSA-N [[(2r,3s,5r)-5-[6-(6-aminohexylamino)purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical class C1=NC=2C(NCCCCCCN)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HSXRRQRNDFXLQW-YNEHKIRRSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- ALXZGCYGHXLBOC-UHFFFAOYSA-N acetamide;2,2,2-trifluoroacetamide Chemical compound CC(N)=O.NC(=O)C(F)(F)F ALXZGCYGHXLBOC-UHFFFAOYSA-N 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 150000001251 acridines Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 108010004469 allophycocyanin Proteins 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000001818 capillary gel electrophoresis Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 235000021158 dinner Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000001803 electron scattering Methods 0.000 description 1
- 238000004865 electron tunneling spectroscopy Methods 0.000 description 1
- 238000001652 electrophoretic deposition Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000013090 high-throughput technology Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000004651 near-field scanning optical microscopy Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000012011 nucleophilic catalyst Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000005408 paramagnetism Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 125000001805 pentosyl group Chemical group 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 description 1
- 238000011338 personalized therapy Methods 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical compound NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- NUSQOFAKCBLANB-UHFFFAOYSA-N phthalocyanine tetrasulfonic acid Chemical compound C12=CC(S(=O)(=O)O)=CC=C2C(N=C2NC(C3=CC=C(C=C32)S(O)(=O)=O)=N2)=NC1=NC([C]1C=CC(=CC1=1)S(O)(=O)=O)=NC=1N=C1[C]3C=CC(S(O)(=O)=O)=CC3=C2N1 NUSQOFAKCBLANB-UHFFFAOYSA-N 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000962 poly(amidoamine) Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 108010077051 polycysteine Proteins 0.000 description 1
- 108010094020 polyglycine Proteins 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 108010000222 polyserine Proteins 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000001004 secondary ion mass spectrometry Methods 0.000 description 1
- 239000002094 self assembled monolayer Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 238000004557 single molecule detection Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000011191 terminal modification Methods 0.000 description 1
- 125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- 125000000080 threosyl group Chemical group C1([C@@H](O)[C@H](O)CO1)* 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 108010061936 thynnine Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000000492 total internal reflection fluorescence microscopy Methods 0.000 description 1
- 238000007862 touchdown PCR Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94503107P | 2007-06-19 | 2007-06-19 | |
| US60/945,031 | 2007-06-19 | ||
| US98191607P | 2007-10-23 | 2007-10-23 | |
| US60/981,916 | 2007-10-23 | ||
| US30507P | 2007-10-25 | 2007-10-25 | |
| US61/000,305 | 2007-10-25 | ||
| PCT/US2008/067507 WO2008157696A2 (en) | 2007-06-19 | 2008-06-19 | High throughput nucleic acid sequencing by expansion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2691364A1 CA2691364A1 (en) | 2008-12-24 |
| CA2691364C true CA2691364C (en) | 2020-06-16 |
Family
ID=39986452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2691364A Active CA2691364C (en) | 2007-06-19 | 2008-06-19 | High throughput nucleic acid sequencing by expansion |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US7939259B2 (enExample) |
| EP (2) | EP2952587B1 (enExample) |
| JP (1) | JP5745842B2 (enExample) |
| KR (1) | KR101685208B1 (enExample) |
| CN (1) | CN102083998B (enExample) |
| AU (1) | AU2008265691B2 (enExample) |
| CA (1) | CA2691364C (enExample) |
| DK (1) | DK2171088T3 (enExample) |
| ES (2) | ES2959127T3 (enExample) |
| HK (1) | HK1217736A1 (enExample) |
| IL (2) | IL202821A (enExample) |
| WO (1) | WO2008157696A2 (enExample) |
Families Citing this family (202)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1758981A4 (en) | 2004-05-28 | 2013-01-16 | Wafergen Inc | DEVICES AND METHOD FOR MULTIPLEX ANALYZES |
| WO2007041621A2 (en) * | 2005-10-03 | 2007-04-12 | Xingsheng Sean Ling | Hybridization assisted nanopore sequencing |
| AU2006336311B2 (en) * | 2006-01-19 | 2013-01-24 | Allexcel, Inc. | Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers |
| US8889348B2 (en) * | 2006-06-07 | 2014-11-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by nanopore using modified nucleotides |
| EP3543357A1 (en) | 2007-05-08 | 2019-09-25 | Trustees of Boston University | Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| CN102083998B (zh) * | 2007-06-19 | 2016-08-03 | 斯特拉托斯基因公司 | 通过展开进行高通量核酸测序 |
| EP2201136B1 (en) * | 2007-10-01 | 2017-12-06 | Nabsys 2.0 LLC | Nanopore sequencing by hybridization of probes to form ternary complexes and variable range alignment |
| CN101910410A (zh) * | 2007-10-23 | 2010-12-08 | 斯特拉托斯基因公司 | 通过间隔进行高通量核酸测序 |
| US8262879B2 (en) | 2008-09-03 | 2012-09-11 | Nabsys, Inc. | Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
| US9650668B2 (en) | 2008-09-03 | 2017-05-16 | Nabsys 2.0 Llc | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
| WO2010028140A2 (en) * | 2008-09-03 | 2010-03-11 | Nabsys, Inc. | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
| EP3216874A1 (en) | 2008-09-05 | 2017-09-13 | TOMA Biosciences, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| EP2987864B1 (en) | 2009-01-29 | 2018-04-25 | Stratos Genomics Inc. | Method for detecting an analyte |
| US8455260B2 (en) * | 2009-03-27 | 2013-06-04 | Massachusetts Institute Of Technology | Tagged-fragment map assembly |
| EP2411536B1 (en) * | 2009-03-27 | 2014-09-17 | Nabsys, Inc. | Methods for analyzing biomolecules and probes bound thereto |
| WO2010114842A1 (en) | 2009-03-30 | 2010-10-07 | Ibis Biosciences, Inc. | Bioagent detection systems, devices, and methods |
| AU2010242073C1 (en) | 2009-04-30 | 2015-12-24 | Good Start Genetics, Inc. | Methods and compositions for evaluating genetic markers |
| US12129514B2 (en) | 2009-04-30 | 2024-10-29 | Molecular Loop Biosolutions, Llc | Methods and compositions for evaluating genetic markers |
| US8246799B2 (en) * | 2009-05-28 | 2012-08-21 | Nabsys, Inc. | Devices and methods for analyzing biomolecules and probes bound thereto |
| AU2010301128B2 (en) | 2009-09-30 | 2014-09-18 | Quantapore, Inc. | Ultrafast sequencing of biological polymers using a labeled nanopore |
| US8324914B2 (en) | 2010-02-08 | 2012-12-04 | Genia Technologies, Inc. | Systems and methods for characterizing a molecule |
| US9678055B2 (en) | 2010-02-08 | 2017-06-13 | Genia Technologies, Inc. | Methods for forming a nanopore in a lipid bilayer |
| US9605307B2 (en) | 2010-02-08 | 2017-03-28 | Genia Technologies, Inc. | Systems and methods for forming a nanopore in a lipid bilayer |
| WO2012003330A2 (en) | 2010-06-30 | 2012-01-05 | Stratos Genomics, Inc | Multiplexed identification of nucleic acid sequences |
| US9309556B2 (en) | 2010-09-24 | 2016-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
| US8715933B2 (en) | 2010-09-27 | 2014-05-06 | Nabsys, Inc. | Assay methods using nicking endonucleases |
| US20120135414A1 (en) * | 2010-10-28 | 2012-05-31 | Life Technologies Corporation | Chemically-enhanced primer compositions, methods and kits |
| US8865404B2 (en) * | 2010-11-05 | 2014-10-21 | President And Fellows Of Harvard College | Methods for sequencing nucleic acid molecules |
| US8859201B2 (en) | 2010-11-16 | 2014-10-14 | Nabsys, Inc. | Methods for sequencing a biomolecule by detecting relative positions of hybridized probes |
| US8805095B2 (en) | 2010-12-03 | 2014-08-12 | International Business Machines Corporation | Analysing character strings |
| WO2012088339A2 (en) | 2010-12-22 | 2012-06-28 | Genia Technologies, Inc. | Nanopore-based single dna molecule characterization using speed bumps |
| US9163281B2 (en) | 2010-12-23 | 2015-10-20 | Good Start Genetics, Inc. | Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
| US9109222B2 (en) | 2010-12-27 | 2015-08-18 | Ibis Biosciences, Inc. | Nucleic acid sample preparation methods and compositions |
| US9581563B2 (en) | 2011-01-24 | 2017-02-28 | Genia Technologies, Inc. | System for communicating information from an array of sensors |
| US9110478B2 (en) | 2011-01-27 | 2015-08-18 | Genia Technologies, Inc. | Temperature regulation of measurement arrays |
| WO2012109574A2 (en) * | 2011-02-11 | 2012-08-16 | Nabsys, Inc. | Assay methods using dna binding proteins |
| WO2013022778A1 (en) | 2011-08-05 | 2013-02-14 | Ibis Biosciences, Inc. | Nucleic acid sequencing by electrochemical detection |
| US20160162634A1 (en) | 2011-09-23 | 2016-06-09 | Oxford Nanopore Technologies Limited | Analysis of a polymer comprising polymer units |
| CA2850509C (en) | 2011-10-14 | 2023-08-01 | President And Fellows Of Harvard College | Sequencing by structure assembly |
| WO2014163886A1 (en) | 2013-03-12 | 2014-10-09 | President And Fellows Of Harvard College | Method of generating a three-dimensional nucleic acid containing matrix |
| WO2013096819A2 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Macromolecule positioning by electrical potential |
| WO2013096838A2 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Systems and methods for isolating nucleic acids |
| WO2013096799A1 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Systems and methods for isolating nucleic acids from cellular samples |
| ES2952728T3 (es) | 2011-12-22 | 2023-11-03 | Harvard College | Métodos para la detección de analitos |
| ES2991004T3 (es) | 2011-12-22 | 2024-12-02 | Harvard College | Métodos para la detección de analitos |
| US9970061B2 (en) | 2011-12-27 | 2018-05-15 | Ibis Biosciences, Inc. | Bioagent detection oligonucleotides |
| WO2013102091A1 (en) | 2011-12-28 | 2013-07-04 | Ibis Biosciences, Inc. | Nucleic acid ligation systems and methods |
| WO2013102081A2 (en) | 2011-12-29 | 2013-07-04 | Ibis Biosciences, Inc. | Macromolecule delivery to nanowells |
| ES2665252T3 (es) | 2011-12-30 | 2018-04-25 | Abbott Molecular Inc. | Purificación de ácido nucleico de microorganismos a partir de muestras del hospedador |
| AU2013208757A1 (en) | 2012-01-09 | 2014-07-24 | Oslo Universitetssykehus Hf | Methods and biomarkers for analysis of colorectal cancer |
| WO2013106737A1 (en) | 2012-01-13 | 2013-07-18 | Data2Bio | Genotyping by next-generation sequencing |
| US8986629B2 (en) | 2012-02-27 | 2015-03-24 | Genia Technologies, Inc. | Sensor circuit for controlling, detecting, and measuring a molecular complex |
| ES2716995T3 (es) | 2012-04-03 | 2019-06-18 | Univ Michigan Regents | Biomarcadores asociados con el síndrome del intestino irritable y la enfermedad de Crohn |
| US8209130B1 (en) | 2012-04-04 | 2012-06-26 | Good Start Genetics, Inc. | Sequence assembly |
| US10227635B2 (en) | 2012-04-16 | 2019-03-12 | Molecular Loop Biosolutions, Llc | Capture reactions |
| EP2844767A4 (en) | 2012-05-02 | 2015-11-18 | Ibis Biosciences Inc | SYSTEMS AND METHODS FOR NUCLEIC ACID SEQUENCING |
| WO2013166303A1 (en) | 2012-05-02 | 2013-11-07 | Ibis Biosciences, Inc. | Dna sequencing |
| US9914967B2 (en) | 2012-06-05 | 2018-03-13 | President And Fellows Of Harvard College | Spatial sequencing of nucleic acids using DNA origami probes |
| GB2510719A (en) | 2012-06-15 | 2014-08-13 | Genia Technologies Inc | Chip set-up and high-accuracy nucleic acid sequencing |
| WO2014005076A2 (en) | 2012-06-29 | 2014-01-03 | The Regents Of The University Of Michigan | Methods and biomarkers for detection of kidney disorders |
| CA2878042C (en) | 2012-07-19 | 2017-11-28 | President And Fellows Of Harvard College | Methods of storing information using nucleic acids |
| JP6510978B2 (ja) | 2012-10-16 | 2019-05-08 | アボツト・モレキユラー・インコーポレイテツド | 核酸を配列決定する方法および装置 |
| US9651539B2 (en) | 2012-10-28 | 2017-05-16 | Quantapore, Inc. | Reducing background fluorescence in MEMS materials by low energy ion beam treatment |
| US9605309B2 (en) | 2012-11-09 | 2017-03-28 | Genia Technologies, Inc. | Nucleic acid sequencing using tags |
| US9670526B2 (en) | 2012-11-09 | 2017-06-06 | Stratos Genomics, Inc. | Concentrating a target molecule for sensing by a nanopore |
| GB201222928D0 (en) * | 2012-12-19 | 2013-01-30 | Oxford Nanopore Tech Ltd | Analysis of a polynucleotide |
| US9914966B1 (en) | 2012-12-20 | 2018-03-13 | Nabsys 2.0 Llc | Apparatus and methods for analysis of biomolecules using high frequency alternating current excitation |
| US11505587B2 (en) * | 2013-01-18 | 2022-11-22 | Nanyang Technological University | Method of preparing a keratin-based biomaterial and keratin-based biomaterial formed thereof |
| WO2014113557A1 (en) | 2013-01-18 | 2014-07-24 | Nabsys, Inc. | Enhanced probe binding |
| US9759711B2 (en) | 2013-02-05 | 2017-09-12 | Genia Technologies, Inc. | Nanopore arrays |
| US20140287946A1 (en) | 2013-03-14 | 2014-09-25 | Ibis Biosciences, Inc. | Nucleic acid control panels |
| EP2971171A4 (en) | 2013-03-14 | 2016-11-02 | Abbott Molecular Inc | SYSTEMS AND METHODS FOR MULTIPLEX AMPLIFICATION SPECIFIC TO METHYLATION |
| US20160153029A1 (en) | 2013-03-15 | 2016-06-02 | Ibis Biosciences, Inc. | Dna sequences to assess contamination in dna sequencing |
| CA2905410A1 (en) | 2013-03-15 | 2014-09-25 | Abbott Molecular Inc. | Systems and methods for detection of genomic copy number changes |
| EP3004385B1 (en) * | 2013-05-24 | 2018-11-28 | Quantapore Inc. | Nanopore-based nucleic acid analysis with mixed fret detection |
| KR102884236B1 (ko) | 2013-06-04 | 2025-11-12 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Rna-가이드된 전사 조절 |
| US20150037787A1 (en) * | 2013-07-31 | 2015-02-05 | International Business Machines Corporation | Polynucleotide configuration for reliable electrical and optical sensing |
| EP3879012A1 (en) | 2013-08-19 | 2021-09-15 | Abbott Molecular Inc. | Next-generation sequencing libraries |
| US9551697B2 (en) | 2013-10-17 | 2017-01-24 | Genia Technologies, Inc. | Non-faradaic, capacitively coupled measurement in a nanopore cell array |
| US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
| CA2927752A1 (en) | 2013-10-18 | 2015-04-23 | The Regents Of The University Of Michigan | Systems and methods for determining a treatment course of action |
| US9567630B2 (en) | 2013-10-23 | 2017-02-14 | Genia Technologies, Inc. | Methods for forming lipid bilayers on biochips |
| US10421995B2 (en) | 2013-10-23 | 2019-09-24 | Genia Technologies, Inc. | High speed molecular sensing with nanopores |
| WO2015095355A2 (en) | 2013-12-17 | 2015-06-25 | The Brigham And Women's Hospital, Inc. | Detection of an antibody against a pathogen |
| WO2015107430A2 (en) | 2014-01-16 | 2015-07-23 | Oslo Universitetssykehus Hf | Methods and biomarkers for detection and prognosis of cervical cancer |
| FR3020071B1 (fr) | 2014-04-17 | 2017-12-22 | Dna Script | Procede de synthese d'acides nucleiques, notamment d'acides nucleiques de grande longueur, utilisation du procede et kit pour la mise en œuvre du procede |
| WO2015164602A2 (en) * | 2014-04-23 | 2015-10-29 | Children's Medical Center Corporation | High-throughput structure determination using nucleic acid calipers |
| US20150315637A1 (en) * | 2014-04-30 | 2015-11-05 | International Business Machines Corporation | Bow tie dna compositions and methods |
| US10934581B2 (en) | 2014-04-30 | 2021-03-02 | International Business Machines Corporation | Bow tie DNA compositions and methods |
| WO2015175789A1 (en) | 2014-05-14 | 2015-11-19 | Mcruer Robert N | Translocation control for sensing by a nanopore |
| WO2015188178A1 (en) | 2014-06-06 | 2015-12-10 | The Regents Of The University Of Michigan | Compositions and methods for characterizing and diagnosing periodontal disease |
| CN114214314A (zh) | 2014-06-24 | 2022-03-22 | 生物辐射实验室股份有限公司 | 数字式pcr条码化 |
| WO2015200833A2 (en) | 2014-06-27 | 2015-12-30 | Abbott Laboratories | COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2) |
| WO2016007839A1 (en) | 2014-07-11 | 2016-01-14 | President And Fellows Of Harvard College | Methods for high-throughput labelling and detection of biological features in situ using microscopy |
| EP3835430B1 (en) | 2014-07-24 | 2023-08-16 | Abbott Molecular Inc. | Compositions and methods for the detection and analysis of mycobacterium tuberculosis |
| FR3025201B1 (fr) | 2014-09-02 | 2018-10-12 | Dna Script | Nucleotides modifies pour la synthese d'acides nucleiques, un kit renfermant de tels nucleotides et leur utilisation pour la production de genes ou sequences d'acides nucleiques synthetiques |
| US11408024B2 (en) | 2014-09-10 | 2022-08-09 | Molecular Loop Biosciences, Inc. | Methods for selectively suppressing non-target sequences |
| JP6702951B2 (ja) * | 2014-09-26 | 2020-06-03 | オンテラ インコーポレイテッド | 合成プローブのナノ細孔センシングによる標的配列検出 |
| CN107278234A (zh) * | 2014-10-03 | 2017-10-20 | 生命科技公司 | 基因序列校验组合物、方法和试剂盒 |
| CA2963604C (en) | 2014-10-10 | 2023-02-14 | Quantapore, Inc. | Nanopore-based polymer analysis with mutually-quenching fluorescent labels |
| EP3209800B1 (en) | 2014-10-24 | 2022-02-16 | Quantapore, Inc. | Efficient optical analysis of polymers using arrays of nanostructures |
| AU2015349730C1 (en) * | 2014-11-20 | 2020-04-30 | F. Hoffmann-La Roche Ag | Nulceoside phosphoroamidate esters and derivatives thereof, use and synthesis thereof |
| WO2016090583A1 (zh) * | 2014-12-10 | 2016-06-16 | 深圳华大基因研究院 | 测序数据处理装置和方法 |
| CN107077538B (zh) * | 2014-12-10 | 2020-08-07 | 深圳华大生命科学研究院 | 测序数据处理装置和方法 |
| WO2016090584A1 (zh) * | 2014-12-10 | 2016-06-16 | 深圳华大基因研究院 | 确定肿瘤核酸浓度的方法和装置 |
| US10066259B2 (en) * | 2015-01-06 | 2018-09-04 | Good Start Genetics, Inc. | Screening for structural variants |
| US10208339B2 (en) | 2015-02-19 | 2019-02-19 | Takara Bio Usa, Inc. | Systems and methods for whole genome amplification |
| EP3822361A1 (en) | 2015-02-20 | 2021-05-19 | Takara Bio USA, Inc. | Method for rapid accurate dispensing, visualization and analysis of single cells |
| WO2017011492A1 (en) * | 2015-07-13 | 2017-01-19 | President And Fellows Of Harvard College | Methods for retrievable information storage using nucleic acids |
| WO2017011565A1 (en) | 2015-07-14 | 2017-01-19 | Abbott Molecular Inc. | Compositions and methods for identifying drug resistant tuberculosis |
| US10392613B2 (en) | 2015-07-14 | 2019-08-27 | Abbott Molecular Inc. | Purification of nucleic acids using copper-titanium oxides |
| JP7166168B2 (ja) | 2015-07-30 | 2022-11-07 | マサチューセッツ アイ アンド イヤー インファーマリー | 祖先ウイルス配列およびその使用 |
| GB2559526B (en) | 2015-11-03 | 2021-02-17 | Harvard College | Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix |
| WO2017079593A1 (en) * | 2015-11-04 | 2017-05-11 | Atreca, Inc. | Combinatorial sets of nucleic acid barcodes for analysis of nucleic acids associated with single cells |
| US10745685B2 (en) | 2015-11-16 | 2020-08-18 | Stratos Genomics, Inc. | DP04 polymerase variants |
| WO2017120531A1 (en) | 2016-01-08 | 2017-07-13 | Bio-Rad Laboratories, Inc. | Multiple beads per droplet resolution |
| US10626390B2 (en) | 2016-02-08 | 2020-04-21 | RGENE, Inc. | Multiple ligase compositions, systems, and methods |
| EP3414347A4 (en) * | 2016-02-11 | 2019-10-09 | Qiagen Sciences, LLC | ADDITIVE FOR IMPROVING SEQUENCING THROUGH SYNTHETIC PERFORMANCE |
| US20190062827A1 (en) | 2016-03-14 | 2019-02-28 | RGENE, Inc. | HYPER-THERMOSTABLE LYSINE-MUTANT ssDNA/RNA LIGASES |
| US11486873B2 (en) | 2016-03-31 | 2022-11-01 | Ontera Inc. | Multipore determination of fractional abundance of polynucleotide sequences in a sample |
| CN109415761B (zh) | 2016-04-25 | 2022-09-20 | 哈佛学院董事及会员团体 | 用于原位分子检测的杂交链反应方法 |
| JP2019522983A (ja) | 2016-07-05 | 2019-08-22 | クアンタポール, インコーポレイテッド | 光学ベースのナノポア配列決定 |
| US11091795B2 (en) | 2016-07-11 | 2021-08-17 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for diagnosing and treating arrhythmias |
| IL291323B2 (en) | 2016-07-15 | 2023-09-01 | Am Chemicals Llc | Solid non-nucleoside supports and phosphoramidite building blocks for oligonucleotide synthesis |
| CN109070044B (zh) | 2016-07-21 | 2021-07-30 | 宝生物工程(美国)有限公司 | 使用多孔装置进行的多z平面成像和分配 |
| US11543417B2 (en) | 2016-08-29 | 2023-01-03 | Oslo Universitetssykehus Hf | ChIP-seq assays |
| CN109923216B (zh) | 2016-08-31 | 2024-08-02 | 哈佛学院董事及会员团体 | 将生物分子的检测组合到使用荧光原位测序的单个试验的方法 |
| JP7239465B2 (ja) | 2016-08-31 | 2023-03-14 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 蛍光in situ配列決定による検出のための核酸配列ライブラリの作製法 |
| WO2018064338A1 (en) | 2016-09-29 | 2018-04-05 | Stratos Genomics, Inc. | Directed evolution of enzymes by plasmid tagging in droplets |
| WO2018069484A2 (en) | 2016-10-13 | 2018-04-19 | F. Hoffmann-La Roche Ag | Molecular detection and counting using nanopores |
| CN118441026A (zh) | 2016-12-19 | 2024-08-06 | 生物辐射实验室股份有限公司 | 液滴加标的相邻性保留的标签化dna |
| US11708566B2 (en) | 2017-05-04 | 2023-07-25 | Stratos Genomics, Inc. | DP04 polymerase variants |
| AU2018279728B2 (en) | 2017-06-08 | 2023-07-20 | The Brigham And Women's Hospital, Inc. | Methods and compositions for identifying epitopes |
| US11186862B2 (en) | 2017-06-20 | 2021-11-30 | Bio-Rad Laboratories, Inc. | MDA using bead oligonucleotide |
| US11390856B2 (en) | 2017-08-07 | 2022-07-19 | Dna Script | Variants of family a DNA polymerase and uses thereof |
| EP3704247B1 (en) | 2017-11-02 | 2023-01-04 | Bio-Rad Laboratories, Inc. | Transposase-based genomic analysis |
| US11131646B2 (en) | 2017-11-03 | 2021-09-28 | Robert Bosch Gmbh | Electrochemical sequencing of DNA using an edge electrode |
| WO2019118372A1 (en) | 2017-12-11 | 2019-06-20 | Stratos Genomics, Inc. | Dpo4 polymerase variants with improved accuracy |
| JP7074857B2 (ja) * | 2017-12-21 | 2022-05-24 | エフ.ホフマン-ラ ロシュ アーゲー | 一方向性の核酸配列決定のための組成物及び方法 |
| CN111712584B (zh) | 2018-01-05 | 2025-02-07 | F·霍夫曼-罗氏股份公司 | 由小沟结合部分增强核酸聚合 |
| CA3086893C (en) * | 2018-01-05 | 2024-04-30 | Stratos Genomics, Inc. | Enhancement of nucleic acid polymerization by aromatic compounds |
| US10752887B2 (en) | 2018-01-08 | 2020-08-25 | Dna Script | Variants of terminal deoxynucleotidyl transferase and uses thereof |
| CN112105725A (zh) | 2018-01-08 | 2020-12-18 | Dna斯克瑞普特公司 | 末端脱氧核苷酸转移酶的变体及其用途 |
| JP6559814B2 (ja) * | 2018-01-26 | 2019-08-14 | 株式会社日立ハイテクノロジーズ | 生体分子測定方法 |
| US12209277B2 (en) * | 2018-01-31 | 2025-01-28 | Bio-Rad Laboratories, Inc. | Methods and compositions for deconvoluting partition barcodes |
| WO2019195701A1 (en) | 2018-04-05 | 2019-10-10 | Massachusetts Eye And Ear Infirmary | Methods of making and using combinatorial barcoded nucleic acid libraries having defined variation |
| US11512002B2 (en) | 2018-04-18 | 2022-11-29 | University Of Virginia Patent Foundation | Silica materials and methods of making thereof |
| EP3788377A1 (en) | 2018-05-04 | 2021-03-10 | Abbott Laboratories | Hbv diagnostic, prognostic, and therapeutic methods and products |
| CA3106410A1 (en) | 2018-07-23 | 2020-01-30 | Dna Script | Massively parallel enzymatic synthesis of nucleic acid strands |
| SG11202101934SA (en) | 2018-07-30 | 2021-03-30 | Readcoor Llc | Methods and systems for sample processing or analysis |
| US11479816B2 (en) | 2018-08-20 | 2022-10-25 | Bio-Rad Laboratories, Inc. | Nucleotide sequence generation by barcode bead-colocalization in partitions |
| WO2020076976A1 (en) | 2018-10-10 | 2020-04-16 | Readcoor, Inc. | Three-dimensional spatial molecular indexing |
| US12139764B2 (en) | 2018-11-14 | 2024-11-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems and methods for characterizing and treating breast cancer |
| AU2019398307A1 (en) | 2018-12-13 | 2021-06-10 | Dna Script | Direct oligonucleotide synthesis on cells and biomolecules |
| WO2020165137A1 (en) | 2019-02-12 | 2020-08-20 | Dna Script | Efficient product cleavage in template-free enzymatic synthesis of polynucleotides. |
| CN113631764A (zh) * | 2019-02-21 | 2021-11-09 | 斯特拉托斯基因公司 | 用于固态合成在单分子测序中使用的可扩展聚合物的方法、组合物和装置 |
| AU2020279629B2 (en) | 2019-05-23 | 2023-01-19 | F. Hoffmann-La Roche Ag | Translocation control elements, reporter codes, and further means for translocation control for use in nanopore sequencing |
| WO2020254672A1 (en) | 2019-06-19 | 2020-12-24 | Therycell Gmbh | Spatial characterisation of target structures in a sample |
| US11755922B2 (en) * | 2019-10-04 | 2023-09-12 | The Board Of Trustees Of The University Of Illinois | On-chip nanoscale storage system using chimeric DNA |
| WO2021087118A1 (en) | 2019-10-30 | 2021-05-06 | Stratos Genomics, Inc. | Methods and compositions for assembly of biological nanopores |
| JP7344786B2 (ja) | 2019-12-19 | 2023-09-14 | 株式会社日立製作所 | 溶液中の任意のdna配列を同定する方法 |
| WO2021152586A1 (en) | 2020-01-30 | 2021-08-05 | Yeda Research And Development Co. Ltd. | Methods of analyzing microbiome, immunoglobulin profile and physiological state |
| WO2021214766A1 (en) | 2020-04-21 | 2021-10-28 | Yeda Research And Development Co. Ltd. | Methods of diagnosing viral infections and vaccines thereto |
| WO2021224677A1 (en) | 2020-05-05 | 2021-11-11 | Akershus Universitetssykehus Hf | Compositions and methods for characterizing bowel cancer |
| JP7706479B2 (ja) | 2020-06-10 | 2025-07-11 | エフ. ホフマン-ラ ロシュ アーゲー | 膜における自己制限性プロテイン細孔挿入のためのファラデーシステム及び方法 |
| WO2022020359A1 (en) | 2020-07-24 | 2022-01-27 | The Regents Of The University Of Michigan | Compositions and methods for detecting and treating high grade subtypes of uterine cancer |
| US20220049303A1 (en) | 2020-08-17 | 2022-02-17 | Readcoor, Llc | Methods and systems for spatial mapping of genetic variants |
| CN112201305B (zh) * | 2020-10-12 | 2021-12-07 | 冬青南京生物科技有限公司 | 一种单细胞核中基因数目测定设备 |
| GB202103605D0 (en) | 2021-03-16 | 2021-04-28 | Oxford Nanopore Tech Ltd | Alignment of target and reference sequences of polymer units |
| CN117255945A (zh) | 2021-03-31 | 2023-12-19 | 伊鲁米纳公司 | 纳米孔传感器装置 |
| US20230014008A1 (en) * | 2021-07-13 | 2023-01-19 | 10X Genomics, Inc. | Methods for improving spatial performance |
| CN118266034A (zh) | 2021-10-04 | 2024-06-28 | F·霍夫曼-罗氏股份公司 | 在线碱基识别压缩 |
| WO2023081031A1 (en) | 2021-11-08 | 2023-05-11 | Illumina, Inc. | Identifying nucleotides using changes in impedance between electrodes |
| WO2023186842A1 (en) | 2022-03-28 | 2023-10-05 | F. Hoffmann-La Roche Ag | Synthesis of isomerically pure polyol-based phosphoramidites |
| US20230381718A1 (en) | 2022-03-31 | 2023-11-30 | Illumina Cambridge Limited | Barriers including molecules covalently bonded to amphiphilic molecules, and methods of making the same |
| US20230312857A1 (en) | 2022-03-31 | 2023-10-05 | Illumina Cambridge Limited | Nanopore devices including barriers using polymers with end groups, and methods of making the same |
| EP4499281A1 (en) | 2022-03-31 | 2025-02-05 | Illumina, Inc. | Barriers including cross-linked amphiphilic molecules, and methods of making the same |
| US20250223637A1 (en) | 2022-03-31 | 2025-07-10 | Illumina, Inc. | Devices including osmotically balanced barriers, and methods of making and using the same |
| US20250205655A1 (en) | 2022-03-31 | 2025-06-26 | Illumina, Inc. | Amphiphilic polymers to be used in barriers and preparation thereof, barriers with nanopores and preparation thereof |
| WO2023187081A1 (en) | 2022-03-31 | 2023-10-05 | Illumina Cambridge Limited | Methods for inserting nanopores into polymeric membranes using chaotropic solvents |
| JP2025513682A (ja) | 2022-03-31 | 2025-04-30 | イルミナ インコーポレイテッド | ジブロック又はトリブロックコポリマーを使用するバリアを含むナノポアデバイス、及びその作製方法 |
| JP2025515067A (ja) * | 2022-05-02 | 2025-05-13 | エフ. ホフマン-ラ ロシュ アーゲー | ナノポアシーケンシング中のプルシアンブルー形成を低減する組成物および方法 |
| CN119968469A (zh) | 2022-10-03 | 2025-05-09 | 豪夫迈·罗氏有限公司 | 单分子多分子示踪方法和系统 |
| EP4605545A1 (en) | 2022-10-21 | 2025-08-27 | F. Hoffmann-La Roche AG | Detection of modified nucleobases in nucleic acid samples |
| EP4649168A1 (en) | 2023-01-13 | 2025-11-19 | F. Hoffmann-La Roche AG | Detection of modified nucleobases in dna samples |
| WO2024200192A1 (en) | 2023-03-30 | 2024-10-03 | F. Hoffmann-La Roche Ag | Modulation of target molecule-lipid bilayer interactions |
| CN121057766A (zh) | 2023-05-04 | 2025-12-02 | 豪夫迈·罗氏有限公司 | 经修饰的三嵌段共聚物化合物及其使用方法 |
| WO2024227837A1 (en) | 2023-05-04 | 2024-11-07 | F. Hoffmann-La Roche Ag | Hybrid triblock copolymer membrane compositions and methods for nanopore sequencing |
| WO2024242847A1 (en) | 2023-05-25 | 2024-11-28 | Illumina, Inc. | Methods of making barriers including nanopores and cross¬ linked amphiphilic molecules, and barriers formed using same |
| WO2025082960A1 (en) | 2023-10-18 | 2025-04-24 | F. Hoffmann-La Roche Ag | Dpo4 polymerase variants with improved properties |
| WO2025106652A1 (en) | 2023-11-17 | 2025-05-22 | Illumina, Inc. | Fluidic devices, nanopore instruments, and methods |
| WO2025137293A2 (en) | 2023-12-22 | 2025-06-26 | Roche Sequencing Solutions, Inc. | Enhancement of nucleic acid polymerization by aromatic compounds |
| WO2025132779A2 (en) | 2023-12-22 | 2025-06-26 | F. Hoffmann-La Roche Ag | Methods and compositions for nucleic acid library and template preparation for duplexed sequencing by expansion |
| WO2025132780A2 (en) * | 2023-12-22 | 2025-06-26 | F. Hoffmann-La Roche Ag | Methods and compositions for nucleic acid library and template preparation for duplexed sequencing by expansion |
| WO2025149478A1 (en) | 2024-01-12 | 2025-07-17 | F. Hoffmann-La Roche Ag | Compositions of modified nucleoside triphosphates |
| WO2025149479A1 (en) | 2024-01-12 | 2025-07-17 | Roche Diagnostics Gmbh | Synthesis of modified nucleoside triphosphates |
| WO2025174659A1 (en) | 2024-02-12 | 2025-08-21 | Illumina, Inc. | Net-zero current scheme for nanopore system |
| WO2025174660A1 (en) | 2024-02-12 | 2025-08-21 | Illumina, Inc. | Recharging for nanopore system |
| EP4603180A1 (en) | 2024-02-15 | 2025-08-20 | Roche Diagnostics International AG | Techniques for synthesizing a macromolecule from a sample |
| WO2025212586A1 (en) * | 2024-04-02 | 2025-10-09 | Roche Sequencing Solutions, Inc. | High throughput inramolecular consensus reads |
| WO2025240460A2 (en) | 2024-05-14 | 2025-11-20 | Roche Molecular Systems, Inc. | Assay for detection of mutations conferring resistance to treatment with an immunotherapeutic agent |
| CN118904278A (zh) * | 2024-10-08 | 2024-11-08 | 祥符实验室 | 一种核酸固相合成提取磁珠及其制备方法和应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) * | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US5378825A (en) * | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
| BR9106702A (pt) | 1990-07-27 | 1993-06-08 | Isis Pharmaceuticals Inc | Analogo de oligonucleotideos e processos para modular a producao de uma proteina por um organismo e para tratar um organismo |
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| CA2122365C (en) | 1991-11-26 | 2010-05-11 | Brian Froehler | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| FR2702874B1 (fr) | 1993-03-18 | 1995-06-09 | Centre Nat Rech Scient | Cellule memoire insensible aux rayonnements. |
| ATE154029T1 (de) | 1993-03-30 | 1997-06-15 | Sanofi Sa | 7-deazapurin modifizierte oligonukleotide |
| EP0695306A1 (en) | 1993-04-19 | 1996-02-07 | Gilead Sciences, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
| FR2705099B1 (fr) * | 1993-05-12 | 1995-08-04 | Centre Nat Rech Scient | Oligonucléotides phosphorothioates triesters et procédé de préparation. |
| US6150510A (en) * | 1995-11-06 | 2000-11-21 | Aventis Pharma Deutschland Gmbh | Modified oligonucleotides, their preparation and their use |
| DE4438918A1 (de) * | 1994-11-04 | 1996-05-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
| WO1998023733A2 (en) * | 1996-11-27 | 1998-06-04 | University Of Washington | Thermostable polymerases having altered fidelity |
| US7399844B2 (en) * | 1998-07-09 | 2008-07-15 | Agilent Technologies, Inc. | Method and reagents for analyzing the nucleotide sequence of nucleic acids |
| US6242589B1 (en) | 1998-07-14 | 2001-06-05 | Isis Pharmaceuticals, Inc. | Phosphorothioate oligonucleotides having modified internucleoside linkages |
| US6465193B2 (en) * | 1998-12-11 | 2002-10-15 | The Regents Of The University Of California | Targeted molecular bar codes and methods for using the same |
| NO986133D0 (no) * | 1998-12-23 | 1998-12-23 | Preben Lexow | FremgangsmÕte for DNA-sekvensering |
| EP1196554B1 (en) * | 1999-03-18 | 2009-02-25 | Complete Genomics AS | Methods of cloning and producing fragment chains with readable information content |
| AU5631200A (en) * | 1999-06-22 | 2001-01-09 | President And Fellows Of Harvard College | Control of solid state dimensional features |
| EP1072679A3 (en) * | 1999-07-20 | 2002-07-31 | Agilent Technologies, Inc. (a Delaware corporation) | Method of producing nucleic acid molecules with reduced secondary structure |
| JP2003508063A (ja) * | 1999-09-01 | 2003-03-04 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | オリゴヌクレオチド三リン酸構築ブロックを用いた鋳型依存核酸重合化 |
| US6329178B1 (en) * | 2000-01-14 | 2001-12-11 | University Of Washington | DNA polymerase mutant having one or more mutations in the active site |
| US6951720B2 (en) * | 2001-05-10 | 2005-10-04 | San Diego State University Foundation | Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| GB0308852D0 (en) | 2003-04-16 | 2003-05-21 | Lingvitae As | Method |
| US20070048748A1 (en) * | 2004-09-24 | 2007-03-01 | Li-Cor, Inc. | Mutant polymerases for sequencing and genotyping |
| EP1856280A4 (en) * | 2005-01-12 | 2009-09-09 | Applera Corp | COMPOSITIONS, METHODS AND KITS FOR SELECTIVE AMPLIFICATION OF NUCLEIC ACIDS |
| EP2230315A1 (en) * | 2005-02-01 | 2010-09-22 | AB Advanced Genetic Analysis Corporation | Nucleic acid sequencing by performing successive cycles of duplex extension |
| CN101189345A (zh) * | 2005-02-01 | 2008-05-28 | Ab先进基因分析公司 | 珠基测序的试剂、方法和文库 |
| CN102083998B (zh) * | 2007-06-19 | 2016-08-03 | 斯特拉托斯基因公司 | 通过展开进行高通量核酸测序 |
| CN201189345Y (zh) * | 2008-05-23 | 2009-02-04 | 北京航天长峰股份有限公司 | 一种氧浓度调节装置 |
-
2008
- 2008-06-19 CN CN200880102935.3A patent/CN102083998B/zh active Active
- 2008-06-19 WO PCT/US2008/067507 patent/WO2008157696A2/en not_active Ceased
- 2008-06-19 EP EP15164186.7A patent/EP2952587B1/en active Active
- 2008-06-19 ES ES15164186T patent/ES2959127T3/es active Active
- 2008-06-19 CA CA2691364A patent/CA2691364C/en active Active
- 2008-06-19 JP JP2010513408A patent/JP5745842B2/ja active Active
- 2008-06-19 EP EP08771483.8A patent/EP2171088B1/en active Active
- 2008-06-19 KR KR1020107001274A patent/KR101685208B1/ko active Active
- 2008-06-19 AU AU2008265691A patent/AU2008265691B2/en active Active
- 2008-06-19 US US12/142,221 patent/US7939259B2/en active Active
- 2008-06-19 ES ES08771483.8T patent/ES2559313T3/es active Active
- 2008-06-19 DK DK08771483.8T patent/DK2171088T3/en active
-
2009
- 2009-12-17 IL IL202821A patent/IL202821A/en active IP Right Grant
-
2010
- 2010-10-05 HK HK16105793.0A patent/HK1217736A1/en unknown
-
2011
- 2011-03-30 US US13/075,864 patent/US8349565B2/en active Active
- 2011-03-30 US US13/075,861 patent/US8324360B2/en active Active
-
2012
- 2012-11-30 US US13/691,085 patent/US20130172197A1/en not_active Abandoned
-
2013
- 2013-01-17 IL IL224295A patent/IL224295A/en active IP Right Grant
-
2015
- 2015-07-06 US US14/792,402 patent/US9920386B2/en active Active
-
2018
- 2018-01-30 US US15/883,431 patent/US20180334729A1/en not_active Abandoned
-
2021
- 2021-03-12 US US17/200,642 patent/US20220064741A1/en not_active Abandoned
-
2024
- 2024-05-15 US US18/665,321 patent/US20250109449A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250109449A1 (en) | High throughput nucleic acid sequencing by expansion | |
| US8592182B2 (en) | High throughput nucleic acid sequencing by spacing | |
| EP2391726B1 (en) | High throughput nucleic acid sequencing by expansion and related methods | |
| US20170037456A1 (en) | Multiplexed identification of nucleic acid sequences | |
| HK1143188B (en) | High throughput nucleic acid sequencing by expansion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20130618 |